
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy
Zi‐Jie Long, Jundan Wang, Jue‐Qiong Xu, et al.
Molecular Therapy (2022) Vol. 30, Iss. 3, pp. 1006-1017
Open Access | Times Cited: 49
Zi‐Jie Long, Jundan Wang, Jue‐Qiong Xu, et al.
Molecular Therapy (2022) Vol. 30, Iss. 3, pp. 1006-1017
Open Access | Times Cited: 49
Showing 1-25 of 49 citing articles:
Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study
Jiao Hu, Jinbo Chen, Zhenyu Ou, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 11, pp. 100785-100785
Open Access | Times Cited: 70
Jiao Hu, Jinbo Chen, Zhenyu Ou, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 11, pp. 100785-100785
Open Access | Times Cited: 70
cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors
Guohao Li, Xiangqian Zhao, Zuda Zheng, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 19
Guohao Li, Xiangqian Zhao, Zuda Zheng, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 19
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
Viola Previtali, Greta Bagnolini, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11488-11521
Open Access | Times Cited: 17
Viola Previtali, Greta Bagnolini, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11488-11521
Open Access | Times Cited: 17
The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors
Sami G. Almalki
Pathology - Research and Practice (2023) Vol. 251, pp. 154854-154854
Closed Access | Times Cited: 29
Sami G. Almalki
Pathology - Research and Practice (2023) Vol. 251, pp. 154854-154854
Closed Access | Times Cited: 29
Protective effects of peptide KSPLY derived from Hericium erinaceus on H2O2-induced oxidative damage in HepG2 cells
Zhengli Xu, Qiuhui Hu, Minhao Xie, et al.
Food Science and Human Wellness (2023) Vol. 12, Iss. 5, pp. 1893-1904
Open Access | Times Cited: 23
Zhengli Xu, Qiuhui Hu, Minhao Xie, et al.
Food Science and Human Wellness (2023) Vol. 12, Iss. 5, pp. 1893-1904
Open Access | Times Cited: 23
Transfer of cGAMP from neuron to microglia activates microglial type I interferon responses after subarachnoid hemorrhage
Hanxiao Chang, Zheng Li, Weiwei Zhang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Hanxiao Chang, Zheng Li, Weiwei Zhang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Acid-Responsive Biocompatible Hydrogel Modulating Tumor DNA Self-Repair Collaborated with Chemotherapy for Boosting STING Pathway-Associated Immunotherapy
Yan-Tong Lin, Ran Meng, Shi‐Man Zhang, et al.
Nano Letters (2025)
Closed Access | Times Cited: 1
Yan-Tong Lin, Ran Meng, Shi‐Man Zhang, et al.
Nano Letters (2025)
Closed Access | Times Cited: 1
Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance
Yihang Gao, Chongchong Feng, Jingru Ma, et al.
Biochemical Pharmacology (2024) Vol. 221, pp. 116048-116048
Closed Access | Times Cited: 8
Yihang Gao, Chongchong Feng, Jingru Ma, et al.
Biochemical Pharmacology (2024) Vol. 221, pp. 116048-116048
Closed Access | Times Cited: 8
Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies
Mingqing Huang, Zhuocen Cha, Rui Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Mingqing Huang, Zhuocen Cha, Rui Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Pervasive nuclear envelope ruptures precede ECM signaling and disease onset without activating cGAS-STING in Lamin-cardiomyopathy mice
Atsuki En, Hanumakumar Bogireddi, Briana Thomas, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114284-114284
Open Access | Times Cited: 8
Atsuki En, Hanumakumar Bogireddi, Briana Thomas, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114284-114284
Open Access | Times Cited: 8
CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors
Jiahao Liu, Xiaofei Jiao, Ding Ma, et al.
Med (2024) Vol. 5, Iss. 6, pp. 530-549
Closed Access | Times Cited: 7
Jiahao Liu, Xiaofei Jiao, Ding Ma, et al.
Med (2024) Vol. 5, Iss. 6, pp. 530-549
Closed Access | Times Cited: 7
Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation
Yang Yu, Jingyang Liu, Cun Liu, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3043-3043
Open Access | Times Cited: 27
Yang Yu, Jingyang Liu, Cun Liu, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3043-3043
Open Access | Times Cited: 27
Voltammetric studies and spectroscopic investigations of the interaction of an anticancer drug bevacizumab-DNA and analytical applications of disposable pencil graphite sensor
Mehmet Aslan, Fırat Aydın, Abdulkadır Levent
Talanta (2023) Vol. 265, pp. 124893-124893
Closed Access | Times Cited: 16
Mehmet Aslan, Fırat Aydın, Abdulkadır Levent
Talanta (2023) Vol. 265, pp. 124893-124893
Closed Access | Times Cited: 16
Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4+ T cells through regulating type 2 conventional dendritic cells
Jing Luo, S.S. Pang, Zhenzhen Hui, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4836-4857
Open Access | Times Cited: 15
Jing Luo, S.S. Pang, Zhenzhen Hui, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4836-4857
Open Access | Times Cited: 15
Simple and Smart Metal–Phenolic Micelles for Optimizing Immunotherapy by Disrupting Tumor Stemness
Yaping Wang, Xin Wang, Yuping He, et al.
Nano Letters (2025)
Closed Access
Yaping Wang, Xin Wang, Yuping He, et al.
Nano Letters (2025)
Closed Access
Calothrixin B by docking JAK2 is a potential therapeutic inhibitor for pancreatic ductal adenocarcinoma
Yang Wang, Sayed S. Esa, Rongji Yu, et al.
Journal of Pharmacy and Pharmacology (2025)
Closed Access
Yang Wang, Sayed S. Esa, Rongji Yu, et al.
Journal of Pharmacy and Pharmacology (2025)
Closed Access
Nuclear translocation of CDK5RAP3 regulated by NXF3 promotes the progression of gastric cancer
Cheng Zhang, Dongyang Wang, Yuguang Shen, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Cheng Zhang, Dongyang Wang, Yuguang Shen, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
The cGAS ‐STING‐ related signature affects the prognosis of colorectal cancer through its regulation of multiple immune cells
Yunlong Li, Xunliang Jiang, Hui Cao, et al.
IUBMB Life (2025) Vol. 77, Iss. 3
Open Access
Yunlong Li, Xunliang Jiang, Hui Cao, et al.
IUBMB Life (2025) Vol. 77, Iss. 3
Open Access
Prognostic significance and immune landscape of a cell cycle progression-related risk model in bladder cancer
Zhouting Tuo, Yuan Lin, Ying Zhang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Zhouting Tuo, Yuan Lin, Ying Zhang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Discovery of Airway-Administered Ionophores for Mn2+ to Mitigate Lung Metastasis by Targeting Disseminated Tumor Cell
Yuming Wang, Ni Fan, Rui Wang, et al.
ACS Nano (2025)
Closed Access
Yuming Wang, Ni Fan, Rui Wang, et al.
ACS Nano (2025)
Closed Access
Anlotinib enhances the antitumor immunity of radiotherapy by activating cGAS/STING in non-small cell lung cancer
Dong Han, Jiajia Zhang, Yawei Bao, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Dong Han, Jiajia Zhang, Yawei Bao, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 16
DNA as the main target in radiotherapy—a historical overview from first isolation to anti-tumour immune response
Benjamin Frey, Kerstin Borgmann, Tina Jost, et al.
Strahlentherapie und Onkologie (2023) Vol. 199, Iss. 12, pp. 1080-1090
Closed Access | Times Cited: 9
Benjamin Frey, Kerstin Borgmann, Tina Jost, et al.
Strahlentherapie und Onkologie (2023) Vol. 199, Iss. 12, pp. 1080-1090
Closed Access | Times Cited: 9
Combination of irinotecan silicasome nanoparticles with radiation therapy sensitizes immunotherapy by modulating the activation of the cGAS/STING pathway for colorectal cancer
Lu Wang, Tianyu Zhang, Yile Zheng, et al.
Materials Today Bio (2023) Vol. 23, pp. 100809-100809
Open Access | Times Cited: 8
Lu Wang, Tianyu Zhang, Yile Zheng, et al.
Materials Today Bio (2023) Vol. 23, pp. 100809-100809
Open Access | Times Cited: 8
Glabridin improves autoimmune disease in Trex1-deficient mice by reducing type I interferon production
Jincai Wen, Wenqing Mu, Hui Li, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 8
Jincai Wen, Wenqing Mu, Hui Li, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 8